Most health systems treat life expectancy as the final score. It is a blunt instrument. It ignores the quality of the years leading up to death. Singapore is currently dismantling that assumption. The country has identified a specific, measurable deficit in its female population that standard metrics miss. This is not a minor statistical blip. It is a structural failure in how we measure human worth and health.
On October 8, 2026, Minister for Health Ong Ye Kung stood before the Milken Institute Asia Summit. He did not offer platitudes. He presented a hard truth. While Singaporeans live to an average of 84, the years spent in good health are fewer. For women, the disparity is sharper. This is a critical intersection of biology, equity, and budget that demands immediate, structural attention.
The Numbers Behind the Narrative
Ong Ye Kung cited precise figures that dismantle the myth of aging well. The average Singaporean loses about 10 years to poor health. For men, the gap is slightly under that mark. For women, it stretches to 12 years. This is not a rounding error. It is a significant portion of a life spent in discomfort or decline.
The divergence is stark. Women live 4.5 years longer than men on average. Yet, half of that extra time is spent in ill health. The biological hurdles are distinct. The implications for healthcare planning are profound. This is not just about adding years to life. It is about managing the quality of those years with greater precision and intent.

Fiscal Headroom as a Strategic Advantage
Not every country can afford to pivot from reactive treatment to proactive prevention. Singapore spends around 4.5 percent of its gross domestic product on healthcare. This grants it what Ong called fiscal headroom. This economic stability allows the nation to divide resources between acute care and preventive care without collapsing its system. It is a luxury most nations cannot claim.
Many health ministers lack this luxury. They are constrained by budgets that force them to prioritize immediate, acute interventions over long term wellness. Singapore’s position is unique in this regard. It has the capacity to invest in sex specific health research and preventative treatments that might be financially out of reach for less wealthy nations. This is a structural advantage, not just a budget line.
This capacity is not just about money. It is about the structure of the healthcare workforce. Ong noted that many systems cannot handle the shift to preventive care because their workers are already overwhelmed. Singapore is positioning itself to be an urban environment where this shift is not just possible, but sustainable. It is a deliberate choice to prioritize prevention over crisis management.

A Dialogue on Women's Health
The discussion took place in a high profile setting. It was a dialogue with Dr. Jill Biden, the former first lady of the United States and chair of the Milken Institute Women's Health Network. The session was moderated by Esther Krofah, executive vice president of Health at the Milken Institute. The 13th edition of the summit, running from October 7 to 9, drew approximately 1,500 participants from 50 countries. The stakes were high.
Biden’s presence underscored the global importance of the topic. Her organization focuses specifically on women's health. The conversation with Ong highlighted a shared concern. Current medical models are not fully equipped to address the unique health vulnerabilities of women as they age. The focus is shifting from survival to the quality of survival. This is a fundamental reorientation of medical priorities.

Redefining the Goal of Healthcare
The traditional metric of success in medicine has long been survival. We count the years. But the new challenge, as Ong articulated, is healthy longevity. It is about bridging the morbidity gap. This is the period where a person is alive but not well. This is a fundamental shift in how we define the purpose of a healthcare system. It moves the goalpost from mere existence to functional health.
For women, this shift is particularly urgent. The 12 year gap suggests that the final decade or more of life may be marked by chronic conditions, pain, or reduced mobility. Addressing this requires a different kind of medicine. It must be proactive, personalized, and deeply informed by biological sex differences. These differences have historically been underrepresented in research. Now, they are central to the strategy.
The Path Forward
Singapore’s approach offers a model for other nations. But it also sets a high bar. The investment in preventive care is not a one time expense. It is a continuous commitment to understanding how women’s bodies change over time. It is a recognition that health is not a binary state. It is a spectrum that must be actively managed. This requires sustained political and financial will.
As the world watches this experiment, the key question is whether other countries can find the fiscal and political will to follow suit. The data is clear. The biological reality is undeniable. The next decade of healthcare will be defined by how effectively we can close the gap between living and truly being well. This is not just a Singaporean problem. It is a global imperative.
Frequently asked questions


Comments
0